Abnormal alpha-synuclein interactions with Rab proteins in alpha-synuclein A30P transgenic mice

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Familial Parkinson disease (PD) is a neurodegenerative disorder.
• Alpha-synuclein gene mutations, like A30P, are causative factors in familial PD.
• Understanding the molecular mechanisms of alpha-synuclein aggregation is crucial for PD research.

Purpose of the Study:

• To investigate the pathological consequences of A30P alpha-synuclein mutation in a transgenic mouse model.
• To characterize the motor deficits, protein aggregation, and gliosis in Tg5093 mice.
• To explore the interaction of mutant alpha-synuclein with Rab proteins and its implications for synaptic function.

Main Methods:

• Generation of transgenic mice (Tg5093) expressing mutant human A30P alpha-synuclein.
• Behavioral analysis to assess motor function (tremor, rigidity, dystonia).
• Biochemical analysis of brain homogenates to detect alpha-synuclein aggregates.
• Immunohistochemistry to evaluate gliosis.
• Pull-down assays using Rab proteins to study alpha-synuclein interactions.

Main Results:

• Tg5093 mice exhibited progressive motor disorders and alpha-synuclein accumulation in the CNS.
• Significant gliosis was observed, particularly in the hippocampal formation.
• Alpha-synuclein aggregates were detected in soluble fractions of Tg mouse brains.
• Mutant alpha-synuclein specifically interacted with Rab3a, Rab5, and Rab8 proteins.

Conclusions:

• The A30P alpha-synuclein mutation induces a Parkinson's-like phenotype in mice.
• Alpha-synuclein aggregation and gliosis are key pathological features.
• Interactions between mutant alpha-synuclein and Rab proteins suggest impaired synaptic vesicle trafficking and transport pathways.